News

Filter

Current filters:

Generics

1226 to 1235 of 96320 results

Statin drugs may do more harm than good, article claims

13-06-2014

Statins, already the most prescribed drugs in history, are being recommended for more and more patients…

Cardio-vascularHealthcarePharmaceutical

Meiji Seika Pharma to acquire India’s Medreich for $290 million

Meiji Seika Pharma to acquire India’s Medreich for $290 million

12-06-2014

Japan’s Meiji Seika Pharma revealed today that it intends to acquire all of the outstanding shares…

Asia-PacificGenericsMedreichMeiji Seika PharmaMergers & Acquisitions

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

12-06-2014

Ireland-headquartered drugmaker Shire says it has agreed to a written request by the US Food and Drug…

NeurologicalPharmaceuticalRegulationResearchShireUSAVyvanse

EULAR: Positive Ph III sarilumab data in RA from Sanofi and Regeneron

EULAR: Positive Ph III sarilumab data in RA from Sanofi and Regeneron

12-06-2014

French drug major Sanofi and partner US biotech firm Regeneron Pharmaceuticals have presented positive…

Anti-Arthritics/RheumaticsBiotechnologyRegeneronResearchSanofisarilumab

EULAR: Sustained outcomes with UCB’s Cimzia in spondyloarthritis

EULAR: Sustained outcomes with UCB’s Cimzia in spondyloarthritis

12-06-2014

Belgium’s leading drugmaker UCB today presented new long-term data on Cimzia (certolizumab pegol) in…

Anti-Arthritics/RheumaticsBiotechnologyCimziaResearchUCB

EULAR: High rates of DAS-defined remission with Bristol-Myers’ Orencia in early RA

EULAR: High rates of DAS-defined remission with Bristol-Myers’ Orencia in early RA

12-06-2014

US drug major Bristol-Myers Squibb has released new data from a Phase IIIb RA trial showing that the…

Anti-Arthritics/RheumaticsBiotechnologyBristol-Myers SquibbOrenciaResearch

1226 to 1235 of 96320 results

Back to top